M3, Inc. Overview
Pro stress-test →M3 Inc is a provider of medical-related services through an online platform that allows member physicians to receive frequent and continuous information through the m3.com platform. The company serves 330,000+ Japanese and 6,500,000+ global physician members, making it a critical infrastructure player in global healthcare information and clinical research.
Strategic Profile
Pro stress-test →M3 operates six reportable segments including Medical Platform, Evidence Solutions, Career Solutions, Site Solutions, Patient Solutions, and Overseas, with businesses spanning online marketing for medical professionals, clinical trial support, human resources services, and patient support services. M3 is the first company incorporated after the year 2000 to be included in the Nikkei 225 Index, reflecting its strategic importance in Japan's healthcare ecosystem and strong market position.
Competitive Landscape
Pro stress-test →M3 competes in fragmented healthcare IT and clinical research markets. Direct competitors include Veeva Systems (clinical research), Parexel (CRO services), and regional healthcare platforms. M3's competitive advantages include its large physician network, integrated platform spanning marketing-to-clinical research, and strong Japan market presence. International expansion in evidence solutions and overseas segments positions it against global CRO and healthcare IT players.
Industry Context
M3, Inc. operates in Healthcare Technology & Clinical Research Services.
Key facts
Founded: 2000 · Headquarters: Tokyo, Japan · Employees: 15,360 · Revenue: $2.0B · Market cap: $7.7B